umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Structure-activity relationships for lipoprotein lipase agonists that lower plasma triglycerides in vivo
Umeå universitet, Teknisk-naturvetenskapliga fakulteten, Kemiska institutionen.
Umeå universitet, Medicinska fakulteten, Institutionen för medicinsk biovetenskap, Fysiologisk kemi.
Umeå universitet, Medicinska fakulteten, Institutionen för medicinsk biovetenskap, Fysiologisk kemi.
Umeå universitet, Medicinska fakulteten, Institutionen för medicinsk biovetenskap, Fysiologisk kemi.
Vise andre og tillknytning
2015 (engelsk)Inngår i: European Journal of Medicinal Chemistry, ISSN 0223-5234, E-ISSN 1768-3254, Vol. 103, s. 191-209Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

The risk of cardiovascular events increases in individuals with elevated plasma triglyceride (TG) levels, therefore advocating the need for efficient TG-lowering drugs. In the blood circulation, TG levels are regulated by lipoprotein lipase (LPL), an unstable enzyme that is only active as a non-covalently associated homodimer. We recently reported on a N-phenylphthalimide derivative (1) that stabilizes LPL in vitro, and moderately lowers triglycerides in vivo (Biochem. Biophys. Res. Common. 2014, 450, 1063). Herein, we establish structure activity relationships of 51 N-phenylphthalimide analogs of the screening hit 1. In vitro evaluation highlighted that modifications on the phthalimide moiety were not tolerated and that lipophilic substituents on the central phenyl ring were functionally essential. The substitution pattern on the central phenyl ring also proved important to stabilize LPL However, in vitro testing demonstrated rapid degradation of the phthalimide fragment in plasma which was addressed by replacing the phthalimide scaffold with other heterocyclic fragments. The in vitro potency was retained or improved and substance 80 proved stable in plasma and efficiently lowered plasma TGs in vivo. 2015 The Authors. Published by Elsevier Masson SAS.

sted, utgiver, år, opplag, sider
Elsevier, 2015. Vol. 103, s. 191-209
Emneord [en]
Lipoprotein lipase, LPL, Triglyceride, Structure-activity relationship, Agonist
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-111481DOI: 10.1016/j.ejmech.2015.08.058ISI: 000363344700015PubMedID: 26355531OAI: oai:DiVA.org:umu-111481DiVA, id: diva2:877887
Tilgjengelig fra: 2015-12-08 Laget: 2015-11-13 Sist oppdatert: 2018-06-07bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Caraballo, RemiLarsson, MikaelNilsson, Stefan K.Ericsson, MadeleneQian, WeixingTran, Nam Phuong NguyenKindahl, TomasSaar, ValeriaOlivecrona, GunillaEnquist, Per-AndersElofsson, Mikael

Søk i DiVA

Av forfatter/redaktør
Caraballo, RemiLarsson, MikaelNilsson, Stefan K.Ericsson, MadeleneQian, WeixingTran, Nam Phuong NguyenKindahl, TomasSaar, ValeriaOlivecrona, GunillaEnquist, Per-AndersElofsson, Mikael
Av organisasjonen
I samme tidsskrift
European Journal of Medicinal Chemistry

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 926 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf